Published in J Immunol on May 05, 2010
Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset. Blood (2012) 2.57
Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells. Nat Immunol (2013) 1.95
The intracellular B30.2 domain of butyrophilin 3A1 binds phosphoantigens to mediate activation of human Vγ9Vδ2 T cells. Immunity (2014) 1.57
Human neutrophil clearance of bacterial pathogens triggers anti-microbial γδ T cell responses in early infection. PLoS Pathog (2011) 1.46
Butyrophilin 3A1 plays an essential role in prenyl pyrophosphate stimulation of human Vγ2Vδ2 T cells. J Immunol (2013) 1.39
Deep sequencing of the human TCRγ and TCRβ repertoires suggests that TCRβ rearranges after αβ and γδ T cell commitment. Sci Transl Med (2011) 1.36
The molecular basis for modulation of human Vγ9Vδ2 T cell responses by CD277/butyrophilin-3 (BTN3A)-specific antibodies. J Biol Chem (2012) 1.34
Diversity of γδ T-cell antigens. Cell Mol Immunol (2012) 1.19
Cytokine requirements for the differentiation and expansion of IL-17A- and IL-22-producing human Vgamma2Vdelta2 T cells. J Immunol (2010) 1.18
Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity. Oncoimmunology (2013) 1.06
Indirect stimulation of human Vγ2Vδ2 T cells through alterations in isoprenoid metabolism. J Immunol (2011) 0.97
γδ T cells and their potential for immunotherapy. Int J Biol Sci (2014) 0.97
Evolution of the V, D, and J gene segments used in the primate gammadelta T-cell receptor reveals a dichotomy of conservation and diversity. Proc Natl Acad Sci U S A (2011) 0.94
Regulation and function of IL-17A- and IL-22-producing γδ T cells. Cell Mol Life Sci (2011) 0.91
γδ T cell receptor ligands and modes of antigen recognition. Arch Immunol Ther Exp (Warsz) (2011) 0.91
Human gamma delta T cells: Evolution and ligand recognition. Cell Immunol (2015) 0.90
Effector Vγ9Vδ2 T cells dominate the human fetal γδ T-cell repertoire. Proc Natl Acad Sci U S A (2015) 0.89
Applications of next-generation sequencing to blood and marrow transplantation. Biol Blood Marrow Transplant (2012) 0.89
Sensing of Pyrophosphate Metabolites by Vγ9Vδ2 T Cells. Front Immunol (2015) 0.89
RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell Receptor. Cell Rep (2016) 0.88
Target specificity of an autoreactive pathogenic human γδ-T cell receptor in myositis. J Biol Chem (2012) 0.88
Human γδ T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infection. Nat Immunol (2017) 0.87
Sensor Function for Butyrophilin 3A1 in Prenyl Pyrophosphate Stimulation of Human Vγ2Vδ2 T Cells. J Immunol (2015) 0.86
Evolution and function of the TCR Vgamma9 chain repertoire: It's good to be public. Cell Immunol (2015) 0.86
Vγ9 and Vδ2 T cell antigen receptor genes and butyrophilin 3 (BTN3) emerged with placental mammals and are concomitantly preserved in selected species like alpaca (Vicugna pacos). Immunogenetics (2014) 0.86
Molecules and Mechanisms Implicated in the Peculiar Antigenic Activation Process of Human Vγ9Vδ2 T Cells. Front Immunol (2015) 0.86
High-throughput sequencing of B- and T-lymphocyte antigen receptors in hematology. Blood (2013) 0.85
T-Cell-Based Immunotherapy for Osteosarcoma: Challenges and Opportunities. Front Immunol (2016) 0.84
Metabolic engineering of Salmonella vaccine bacteria to boost human Vγ2Vδ2 T cell immunity. J Immunol (2014) 0.82
The Jekyll and Hyde story of IL17-Producing γδT Cells. Front Immunol (2015) 0.80
Resolving the mystery of pyrophosphate antigen presentation. Nat Immunol (2013) 0.80
Clonal selection in the human Vδ1 T cell repertoire indicates γδ TCR-dependent adaptive immune surveillance. Nat Commun (2017) 0.80
The Vγ9Vδ2 T Cell Antigen Receptor and Butyrophilin-3 A1: Models of Interaction, the Possibility of Co-Evolution, and the Case of Dendritic Epidermal T Cells. Front Immunol (2014) 0.80
Phosphoantigen Presentation to TCR γδ Cells, a Conundrum Getting Less Gray Zones. Front Immunol (2015) 0.80
Identification of a new tuberculosis antigen recognized by γδ T cell receptor. Clin Vaccine Immunol (2013) 0.79
Immunogenic and antioxidant effects of a pathogen-associated prenyl pyrophosphate in Anopheles gambiae. PLoS One (2013) 0.78
Adoptive cell therapy for sarcoma. Immunotherapy (2015) 0.78
Flanking V and J sequences of complementary determining region 3 of T cell receptor (TCR) δ1 (CDR3δ1) determine the structure and function of TCRγ4δ1. J Biol Chem (2011) 0.77
Nonclassical T cells and their antigens in tuberculosis. Cold Spring Harb Perspect Med (2014) 0.75
T cell recognition of non-peptidic antigens in infectious diseases. Indian J Med Res (2013) 0.75
Butyrophilin 3A1 presents phosphoantigens to human γδ T cells: the fourth model of antigen presentation in the immune system. Cell Mol Immunol (2013) 0.75
Human γδT-cell subsets and their involvement in tumor immunity. Cell Mol Immunol (2016) 0.75
Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci U S A (2001) 42.14
T-cell antigen receptor genes and T-cell recognition. Nature (1988) 16.77
Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature (1996) 6.20
CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature (2007) 5.31
Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. Nature (1995) 5.04
Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain. J Exp Med (1993) 4.80
Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science (1998) 3.64
A structural basis for the selection of dominant alphabeta T cell receptors in antiviral immunity. Immunity (2003) 3.41
Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire. J Exp Med (1990) 3.38
CDR3 length in antigen-specific immune receptors. J Exp Med (1994) 3.35
The crystal structure of a T cell receptor in complex with peptide and MHC class II. Science (1999) 3.23
Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer. Cancer Res (2007) 3.22
How a single T cell receptor recognizes both self and foreign MHC. Cell (2007) 3.20
Germline-encoded recognition of diverse glycolipids by natural killer T cells. Nat Immunol (2007) 3.19
A structural basis for immunodominant human T cell receptor recognition. Nat Immunol (2003) 3.15
Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells. J Exp Med (2003) 3.13
Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gamma delta T cells. Immunity (1995) 3.12
The gamma delta T cell receptor. Adv Immunol (1988) 3.06
Unconventional topology of self peptide-major histocompatibility complex binding by a human autoimmune T cell receptor. Nat Immunol (2005) 3.05
Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections. Science (2002) 3.01
Diversity of murine gamma genes and expression in fetal and adult T lymphocytes. Nature (1986) 2.89
Harnessing invariant NKT cells in vaccination strategies. Nat Rev Immunol (2009) 2.79
Differential recognition of CD1d-alpha-galactosyl ceramide by the V beta 8.2 and V beta 7 semi-invariant NKT T cell receptors. Immunity (2009) 2.61
Gammadelta T cells for immune therapy of patients with lymphoid malignancies. Blood (2003) 2.57
A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule. Nat Immunol (2007) 2.55
T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide. Nat Immunol (2005) 2.52
Recognition of self antigens by skin-derived T cells with invariant gamma delta antigen receptors. Science (1991) 2.49
Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vgamma2Vdelta2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens. Immunol Rev (2007) 2.46
The CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognition. Nat Immunol (2005) 2.38
Crystal structure of a T cell receptor bound to an allogeneic MHC molecule. Nat Immunol (2000) 2.37
Nonpeptide ligands for human gamma delta T cells. Proc Natl Acad Sci U S A (1994) 2.33
Structure of a gammadelta T cell receptor in complex with the nonclassical MHC T22. Science (2005) 2.32
Crossreactive T Cells spotlight the germline rules for alphabeta T cell-receptor interactions with MHC molecules. Immunity (2008) 2.31
The structural dynamics and energetics of an immunodominant T cell receptor are programmed by its Vbeta domain. Immunity (2008) 2.31
Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids. Immunity (1998) 2.31
Self-recognition of CD1 by gamma/delta T cells: implications for innate immunity. J Exp Med (2000) 2.30
Antigen recognition determinants of gammadelta T cell receptors. Science (2005) 2.14
Human gamma delta T cells recognize alkylamines derived from microbes, edible plants, and tea: implications for innate immunity. Immunity (1999) 2.14
Specific antigen-Ia activation of transfected human T cells expressing murine Ti alpha beta-human T3 receptor complexes. Nature (1987) 2.11
CDR3 loop flexibility contributes to the degeneracy of TCR recognition. Nat Immunol (2003) 2.10
Selection by two powerful antigens may account for the presence of the major population of human peripheral gamma/delta T cells. J Exp Med (1991) 2.09
Tumor recognition following Vgamma9Vdelta2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I. Immunity (2005) 2.08
The shaping of T cell receptor recognition by self-tolerance. Immunity (2009) 2.06
Gamma/delta T-cell stimulation by pamidronate. N Engl J Med (1999) 2.04
Structure of an autoimmune T cell receptor complexed with class II peptide-MHC: insights into MHC bias and antigen specificity. Immunity (2005) 2.03
Structure of a covalently stabilized complex of a human alphabeta T-cell receptor, influenza HA peptide and MHC class II molecule, HLA-DR1. EMBO J (2000) 2.00
Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule. EMBO J (2005) 1.98
Identification of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate as a major activator for human gammadelta T cells in Escherichia coli. FEBS Lett (2001) 1.96
A correlation between TCR Valpha docking on MHC and CD8 dependence: implications for T cell selection. Immunity (2003) 1.95
The fidelity, occasional promiscuity, and versatility of T cell receptor recognition. Immunity (2008) 1.89
Adaptability of the semi-invariant natural killer T-cell receptor towards structurally diverse CD1d-restricted ligands. EMBO J (2009) 1.88
T cell receptor CDR2 beta and CDR3 beta loops collaborate functionally to shape the iNKT cell repertoire. Immunity (2009) 1.85
Alanine scanning mutagenesis of an alphabeta T cell receptor: mapping the energy of antigen recognition. Immunity (1998) 1.80
A T cell receptor CDR3beta loop undergoes conformational changes of unprecedented magnitude upon binding to a peptide/MHC class I complex. Immunity (2002) 1.79
V gamma 2V delta 2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer. J Immunol (1995) 1.73
Granulysin-dependent killing of intracellular and extracellular Mycobacterium tuberculosis by Vgamma9/Vdelta2 T lymphocytes. J Infect Dis (2001) 1.72
Antigen recognition by human gamma delta T cells: pattern recognition by the adaptive immune system. Springer Semin Immunopathol (2000) 1.71
Early activation of human V gamma 9V delta 2 T cell broad cytotoxicity and TNF production by nonpeptidic mycobacterial ligands. J Immunol (1995) 1.70
Molecular recognition of lipid antigens by T cell receptors. J Exp Med (1999) 1.65
Structure of a human gammadelta T-cell antigen receptor. Nature (2001) 1.65
A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR. J Exp Med (2008) 1.60
In vivo immunomanipulation of V gamma 9V delta 2 T cells with a synthetic phosphoantigen in a preclinical nonhuman primate model. J Immunol (2005) 1.57
On the road: progress in finding the unique pathway of invariant NKT cell differentiation. Curr Opin Immunol (2007) 1.50
Close correlation between Daudi and mycobacterial antigen recognition by human gamma delta T cells and expression of V9JPC1 gamma/V2DJC delta-encoded T cell receptors. J Immunol (1993) 1.46
How much can a T-cell antigen receptor adapt to structurally distinct antigenic peptides? EMBO J (2007) 1.44
Crucial role of TCR gamma chain junctional region in prenyl pyrophosphate antigen recognition by gamma delta T cells. J Immunol (1998) 1.42
Definition of APC presentation of phosphoantigen (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate to Vgamma2Vdelta 2 TCR. J Immunol (2008) 1.39
Ontogeny of gamma delta T cells in humans. J Immunol (2004) 1.37
In vitro stimulation with a non-peptidic alkylphosphate expands cells expressing Vgamma2-Jgamma1.2/Vdelta2 T-cell receptors. Immunology (2001) 1.36
Pharmacological interaction of drugs with immune receptors: the p-i concept. Allergol Int (2006) 1.35
An autonomous CDR3delta is sufficient for recognition of the nonclassical MHC class I molecules T10 and T22 by gammadelta T cells. Nat Immunol (2008) 1.33
Activation of C-C beta-chemokines in human peripheral blood gammadelta T cells by isopentenyl pyrophosphate and regulation by cytokines. Blood (2000) 1.31
Single-cell cytokine analysis of gamma delta T cell responses to nonpeptide mycobacterial antigens. J Immunol (1997) 1.30
Peripheral selection of antigen receptor junctional features in a major human gamma delta subset. Eur J Immunol (1993) 1.28
T cell receptor recognition via cooperative conformational plasticity. J Mol Biol (2006) 1.28
Preferential recognition of a microbial metabolite by human Vgamma2Vdelta2 T cells. Int Immunol (2007) 1.24
Structural basis for a major histocompatibility complex class Ib-restricted T cell response. Nat Immunol (2006) 1.23
Structural basis for the recognition of mutant self by a tumor-specific, MHC class II-restricted T cell receptor. Nat Immunol (2007) 1.22
Functionally distinct subsets of human gamma/delta T cells. Eur J Immunol (1991) 1.21
Restricted diversity of V gamma 9-JP rearrangements in unstimulated human gamma/delta T lymphocytes. Eur J Immunol (1992) 1.19
Photoaffinity antigens for human gammadelta T cells. J Immunol (2008) 1.19
Quantitative structure-activity relationships for gammadelta T cell activation by bisphosphonates. J Med Chem (2004) 1.16
Conservation of nonpeptide antigen recognition by rhesus monkey V gamma 2V delta 2 T cells. J Immunol (2003) 1.15
Requirement of species-specific interactions for the activation of human gamma delta T cells by pamidronate. J Immunol (2003) 1.15
Essential contribution of germline-encoded lysine residues in Jgamma1.2 segment to the recognition of nonpeptide antigens by human gammadelta T cells. J Immunol (2001) 1.12
Alkylamines cause Vgamma9Vdelta2 T-cell activation and proliferation by inhibiting the mevalonate pathway. Blood (2005) 1.10
TCR usage and functional capabilities of human gamma delta T cells at birth. J Immunol (1994) 1.10
Recognition of self-peptide-MHC complexes by autoimmune T-cell receptors. Trends Biochem Sci (2007) 1.07
Structural features of nonpeptide prenyl pyrophosphates that determine their antigenicity for human gamma delta T cells. J Immunol (2001) 1.06
Where do MAIT cells fit in the family of unconventional T cells? PLoS Biol (2009) 1.02
Human Vgamma2Vdelta2 T cells contain cytoplasmic RANTES. Int Immunol (2006) 1.00
Recognition of nonpeptide antigens by human V gamma 9V delta 2 T cells requires contact with cells of human origin. Clin Exp Immunol (2004) 0.99
Recognition mechanism of non-peptide antigens by human gammadelta T cells. Int Immunol (2003) 0.99
fldA is an essential gene required in the 2-C-methyl-D-erythritol 4-phosphate pathway for isoprenoid biosynthesis. FEBS Lett (2005) 0.98
Gamma delta T cell receptors. Cell Mol Life Sci (2006) 0.97
Structure of gammadelta T cell receptors and their recognition of non-peptide antigens. Mol Immunol (2002) 0.92
Superantigen recognition by gammadelta T cells: SEA recognition site for human Vgamma2 T cell receptors. Immunity (2001) 0.92
Responses of bovine WC1(+) gammadelta T cells to protein and nonprotein antigens of Mycobacterium bovis. Infect Immun (2002) 0.91
Release of LL-37 by activated human Vgamma9Vdelta2 T cells: a microbicidal weapon against Brucella suis. J Immunol (2006) 0.90
Functional and structural similarity of V gamma 9V delta 2 T cells in humans and Aotus monkeys, a primate infection model for Plasmodium falciparum malaria. J Immunol (2001) 0.90
Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections. Science (2002) 3.01
CD1-mediated gamma/delta T cell maturation of dendritic cells. J Exp Med (2002) 1.56
Butyrophilin 3A1 plays an essential role in prenyl pyrophosphate stimulation of human Vγ2Vδ2 T cells. J Immunol (2013) 1.39
Flexible migration program regulates gamma delta T-cell involvement in humoral immunity. Blood (2003) 1.32
Preferential recognition of a microbial metabolite by human Vgamma2Vdelta2 T cells. Int Immunol (2007) 1.24
Photoaffinity antigens for human gammadelta T cells. J Immunol (2008) 1.19
Cytokine requirements for the differentiation and expansion of IL-17A- and IL-22-producing human Vgamma2Vdelta2 T cells. J Immunol (2010) 1.18
Quantitative structure-activity relationships for gammadelta T cell activation by bisphosphonates. J Med Chem (2004) 1.16
Conservation of nonpeptide antigen recognition by rhesus monkey V gamma 2V delta 2 T cells. J Immunol (2003) 1.15
Pyridinium-1-yl bisphosphonates are potent inhibitors of farnesyl diphosphate synthase and bone resorption. J Med Chem (2005) 1.12
Isoprenoid biosynthesis as a drug target: bisphosphonate inhibition of Escherichia coli K12 growth and synergistic effects of fosmidomycin. J Med Chem (2006) 1.09
Lipophilic pyridinium bisphosphonates: potent gammadelta T cell stimulators. Angew Chem Int Ed Engl (2010) 1.03
Phosphonosulfonates are potent, selective inhibitors of dehydrosqualene synthase and staphyloxanthin biosynthesis in Staphylococcus aureus. J Med Chem (2009) 0.99
fldA is an essential gene required in the 2-C-methyl-D-erythritol 4-phosphate pathway for isoprenoid biosynthesis. FEBS Lett (2005) 0.98
Indirect stimulation of human Vγ2Vδ2 T cells through alterations in isoprenoid metabolism. J Immunol (2011) 0.97
Zoledronic acid-induced expansion of γδ T cells from early-stage breast cancer patients: effect of IL-18 on helper NK cells. Cancer Immunol Immunother (2012) 0.95
Structural studies of Vgamma2Vdelta2 T cell phosphoantigens. Chem Biol (2006) 0.94
Chemo-Immunotherapeutic Anti-Malarials Targeting Isoprenoid Biosynthesis. ACS Med Chem Lett (2013) 0.91
Regulation and function of IL-17A- and IL-22-producing γδ T cells. Cell Mol Life Sci (2011) 0.91
Calmodulin kinase II regulates the maturation and antigen presentation of human dendritic cells. J Leukoc Biol (2005) 0.87
Synthesis of chiral phosphoantigens and their activity in gamma delta T cell stimulation. Bioorg Med Chem Lett (2004) 0.84
Comparison of γδ T cell responses and farnesyl diphosphate synthase inhibition in tumor cells pretreated with zoledronic acid. Cancer Sci (2013) 0.84
Phenotypic and functional alterations of Vgamma2Vdelta2 T cell subsets in patients with active nasopharyngeal carcinoma. Cancer Immunol Immunother (2008) 0.82
Identification of guinea pig gammadelta T cells and characterization during pulmonary tuberculosis. Vet Immunol Immunopathol (2004) 0.80
Identification of an important immunological difference between virulent varicella-zoster virus and its avirulent vaccine: viral disruption of dendritic cell instruction. J Immunol (2010) 0.79
A crystallographic investigation of phosphoantigen binding to isopentenyl pyrophosphate/dimethylallyl pyrophosphate isomerase. J Am Chem Soc (2005) 0.76
Synthesis and immunological evaluation of the 4-β-glucoside of HMBPP. Bioorg Med Chem Lett (2011) 0.76
Necroptosis of Dendritic Cells Promotes Activation of γδ T Cells. J Innate Immun (2016) 0.75